Disease Biomarkers in Gastrointestinal Malignancies.

about

Disease Biomarkers in Gastrointestinal Malignancies.

Item

http://www.wikidata.org/entity/Q42416485

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Disease Biomarkers in Gastrointestinal Malignancies.

@en

Disease Biomarkers in Gastrointestinal Malignancies.

@nl

type

Item

label

Disease Biomarkers in Gastrointestinal Malignancies.

@en

Disease Biomarkers in Gastrointestinal Malignancies.

@nl

prefLabel

Disease Biomarkers in Gastrointestinal Malignancies.

@en

Disease Biomarkers in Gastrointestinal Malignancies.

@nl

P1476

Disease Biomarkers in Gastrointestinal Malignancies

@en

P2093

Hamid Raziee

http://www.w3.org/2001/XMLSchema#string

Mohammad Reza Abbaszadegan

http://www.w3.org/2001/XMLSchema#string

Wilbur Bowne

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted therapy for HM1.24 (CD317) on multiple myeloma cells

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.

Osteopontin as a potential diagnostic biomarker for ovarian cancer.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.

Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma.

Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.

HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing.

P304

4714910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1155/2016/4714910

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Omeed Moaven

Bryan C Fuchs

P577

2016-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27445424

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4947494

http://www.w3.org/2001/XMLSchema#string